Triple negative breast cancer (TNBC) comprises invasive breast tumors which lack the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor type 2 (HER2) overexpression/HER2 gene amplification. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.